Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Immunocore Holdings plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Immunocore Holdings plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Peterson Kristine | Director | – | May 28, 2026 | 1 |
| Pao William | Director | – | May 28, 2026 | 1 |
| Ratcliffe Peter John | Director | – | May 28, 2026 | 1 |
| Herbst Roy Steven | Director | – | May 28, 2026 | 1 |
| Kaul Siddharth | Director | – | May 28, 2026 | 1 |
| Bell John Irving | Director | – | May 28, 2026 | 1 |
| Jallal Bahija | CHIEF EXECUTIVE OFFICER | 12,343 | Feb 19, 2026 | 1 |
| Goll John | SVP, FINANCE & CAO | 653 | Feb 19, 2026 | 1 |
| Berman David M | HEAD OF R&D | 5,859 | Feb 19, 2026 | 5 |
| Coy Travis Alan | Chief Financial Officer | – | Feb 19, 2026 | 1 |
| St Leger Tina Amber | CHIEF HR OFFICER | 1,119 | Feb 19, 2026 | 1 |
| Baker Julian | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| Baker Felix | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| Baker Bros. Advisors LP | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| Baker Brothers Life Sciences LP | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| 667, L.P. | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| Baker Bros. Advisors (GP) LLC | Director | 2,144,060Indirect | May 19, 2025 | 0 |
| Di Donato Brian | CHIEF FINANCIAL OFFICER | – | Feb 21, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | St Leger Tina AmberCHIEF HR OFFICER | SSale | −1.00K | $32.35 | −$32.4K | −47.2%1.12K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Berman David MHEAD OF R&D | SSale | −5.96K | $32.35 | −$193.0K | −50.4%5.86K after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Goll JohnSVP, FINANCE & CAO | SSale | −698 | $32.35 | −$22.6K | −51.7%653 after | |
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Jallal BahijaCHIEF EXECUTIVE OFFICER | SSale | −11.5K | $32.35 | −$371.2K | −48.2%12.3K after | |
| Dec 8, 2025 (view filing) | Dec 4-5 | 4 days | Berman David MHEAD OF R&D | SSale | −31.9K | $40.26 | −$1.28M | −100.0%0 after | 2 lots10b5-1 |
| Dec 1, 2025 (view filing) | Nov 26-28 | 5 days | Berman David MHEAD OF R&D | SSale | −74.9K | $40.12 | −$3.01M | −100.0%0 after | 2 lots10b5-1 |
| Nov 26, 2025 (view filing) | Nov 24-25 | 2 days | Berman David MHEAD OF R&D | SSale | −18.1K | $40.03 | −$725.3K | −100.0%0 after | 2 lots10b5-1 |
| Oct 2, 2025 (view filing) | Sep 30 | 2 days | Berman David MHEAD OF R&D | SSale | −61.8K | $35.23 | −$2.18M | −100.0%0 after | 10b5-1 |
| Sep 16, 2025 (view filing) | Sep 12-15 | 4 days | Berman David MHEAD OF R&D | SSale | −22.7K | $35.66 | −$810.7K | −100.0%0 after | 3 lots10b5-1 |
| Sep 12, 2025 (view filing) | Sep 10-11 | 2 days | Berman David MHEAD OF R&D | SSale | −50.4K | $36.20 | −$1.82M | −100.0%0 after | 3 lots10b5-1 |
| Mar 19, 2025 (view filing)6:40 PM ET | Mar 17 | 2 days | Baker Julian and 5 othersDirector | PPurchaseAmerican Depositary Shares | +807.3K | $29.72 | +$24.0M | +60.4%2.14M after | 4 lots |
| Mar 19, 2025 (view filing)6:40 PM ET | Mar 17 | 2 days | Baker Julian and 5 othersDirector | SSaleAmerican Depositary Shares | −1.58M | – | – | –0 after | Derivative2 lotsPrice outlier |
| Apr 3, 2024 (view filing) | Apr 1 | 2 days | St Leger Tina AmberCHIEF HR OFFICER | SSale | −4.38K | $64.06 | −$280.3K | −100.0%0 after | 10b5-1 |
| Mar 1, 2024 (view filing) | Feb 28 | 2 days | Berman David MHEAD OF R&D | SSale | −36.5K | $68.59 | −$2.50M | −100.0%0 after | 4 lots10b5-1 |
| Feb 28, 2024 (view filing) | Feb 26-27 | 2 days | Berman David MHEAD OF R&D | SSale | −83.5K | $70.79 | −$5.91M | −100.0%0 after | 6 lots10b5-1 |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | St Leger Tina AmberChief HR Officer | SSale | −4.38K | $69.89 | −$305.8K | −100.0%0 after | 2 lots10b5-1 |